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Fig. 3. Immunoelectrophoretic analyses of
type C and type Z myeloma a2-globulins
before and after digestion with papain for
4 and 18 hours.

as the F' arc is unchanged in intensity
as compared with the pattern of the
4-hour digest. In contrast to this behavior, the case V (Z) protein, after
4 hours of papain digestion, shows a
marked diminution in intensity and a
cathodal displacement of the major precipitin arc (FS) without the development of an F' arc. Treatment of the
case V (Z) protein for 18 hours destroyed all material precipitable by the
antiserum to the case II protein.
We then studied the comparative effects of papain treatment on six type
C and the two type Z myeloma y2globulins. Representative results of
these studies are shown in Fig. 3. These
patterns were made with the antiserum
to the case II protein, which develops
only the F and F' arcs, and an antiserum to normal 7S y2-globulin ( antiy2)
which also demonstrates the S
(slow) fragment. The type C myeloma
y2-globulin,after 4 hours of papain digestion, shows strong F and F' arcs in
addition to an S arc. After 18 hours of
digestion, these three arcs are still visible, although attenuated, and it is evident that the F arc has been diminished
to a greater degree than the F' and S
arcs. In contrast to this behavior, the
type Z myeloma y2-globulins after 4
hours of papain treatment, shows a
prominent S arc, only a very faint trace
of an F arc, and no F' arc. After di500

only the S arc
remains. The faint inner arc visible in
the pattern of the undigested type Z
myeloma y2-globulin developed with
the antiserum to the case II protein
probably represents a small amount of
normal 7S y2-globulins and the very
faint F arc seen after 4 hours of digestion may have been derived from that
source.
These observations establish the existence of major structural diSerences
between type C and type Z myeloma
ybglobulins which are comparable to
the demonstrated differences in the
type C and Z proteins in "Heavy
(Hy2) chain" disease. These structural
differences are reflected in greater susceptibility to papain digestion of type Z
than of type C proteins, and the development of an F' component after
papain treatment of type C but not of
type Z proteins. Because of the greater
susceptibility of type Z molecules to
papain degradation, it would be anticipated that the isolated F fragment of
papain-treated pooled normal 7S y2globulin would contain exclusively type
C molecules, and this has been demonstrated.
Within the obvious and generally
recognized limitations of the nomenclature systems now used, the structural differences demonstrated in these
studies are tentatively assigned to the
H-chains, and more specifically to the
portion of the H-chain contained in
the F fragment of papain-treated 75

uent L-chains. The two type Z myeloma
Py2-globulinswere of antigenic group I.
At present, therefore, there appears to be
no correlation between the antigenic types
of the constituent Hwhains (that is, C
or Z) and the constituent L-chains (I or II)
of these proteins.
9. Papain digestion was carried out according
to the procedure of R. R. Porter, Bioc*em.
J. 73, 119 ( 1956). We used twice-crystallized
papain (Worthington Biochemical Corp.)
( 1 mg papain per 100 mg protein) in the
presence of 0.01M cysteine and 0.0021S
ethylenediamine-tetraaceticacid (EDTA) at
pH 5.6 and at 37°C.
10. These studies were supported by NIH grant
CAX2332.
* Research trainee of the National Cancer
Institute (CRTY 5011).
t Faculty Research Associate of the American
Cancer Society.
9 April 1964

Resistance to the Chemical Stenlant,
Apholate, in Aedes aegypti
Abstract. lncreased resistance to the
sterilizing ef ects of apholate was observed in two colonies of Aedes aegypti
(L.) exposed in the larval stage of each
generation to concentrations of apholate that induced about 90 to 40 percent sterility in the eggs laid by the
ensuiog adults.

Since the inception of research on
the potential of chemosterilants as illsect control agents, many persons have
asked whether insects could develop
resistance to the sterilizing effects of
these compounds. On the other hand,
because the action of certain chemosterilants influences the induction of
dominant lethal mutations, it has been
y2-globulin.
KIYOSHI
TAKATSUKI*theorized that continued exposure to
ELLIOTT
F. OSSERMANTsubsterilizing dosages or to dosages
causing only partial sterility might reDepartment of Medicine,
sult in accumulation of genetic defects
College of Physicians and Surgeons,
and ultimate death of a colony.
Columbia University,
In 1962 efforts were initiated to
New York 10032
determine whether the yellow fever
mosquito, Aedes aegypti (L.), could
References and Notes
develop resistance to apholate (1).
1. Since the precise structure and polypeptide
Weidhaas et al. (2) had reported that
composition of the a-globulins are unknown
the designations of the enzymatically and
sterility could be induced in A. aegypti
chemically produced subunits as well as
the subunits which are found in the
by feeding adult mosquitoes on honey
various plasma cell dyscrasias, including
solution containing 0.1 percent of
this disease, must be recognized as tentative.
2. E. C. Franklin, M. Meltzer, F. Guggenapholate. Weidhaas (3) had also demheim, J. Lowenstein, Federation Proc. 22,
onstrated that exposure of larvae of
264 (1963).
3. E. F. Osserman and K. Takatsuki, Medicine A. aegypti, from the third instar to
42, 357 (1963).
pupation, in water containing 10 parts
4. E. C. Franklin, J. Lowenstein, B. Bigelow
M. Meltzer, Am. J. Med., in press.
of
apholate per million produced about
5. E. F. Osserman and K. Takatsuki, ibid., in
90 percent sterility in the ensuing males
press.
6. It is a useful coincidence that the initial, C,
and about 50 percent sterility in feof Franklin's first case corresponds to the
"common" antigenic type, and that the
males. When both sexes were treated,
initial of our case which is representative
sterility was about 98 percent. In later
of the rare antigenic type is Z.
7. R. E. Ballieux, G. Bernier, K. Tominaga, experiments at this laboratory sterility
F. W. Putnam, unpublished observations.
8. The group of 18 myeloma fy2-globulinswhich induced by this larval treatment somewere demonstrated to be of type C in- times reached 100 percent. For our
cluded proteins of both antigenic group I
and group II with respect to their constit- experiments in development of resistSCIENCE, VOL. 145

ance, selection pressure was exerted by
treatmentin the larval stage.
Two different colonies of A. aegypti
were subjected to selection. Treatment
of the first colony began in December
1962, and a second colony was subjected to selection pressure beginning
in July 1963.
The strain of A. aegypti used in
both experiments was from our regular
colony, maintained at this laboratory
for more than 20 years without deliberate exposure to insecticides. In each
generation several hundred third-instar
larvae were placed in shallow exposure
panslthat contained 1 liter of a solution of apholate (S ppm) in tapwater.
In the first experiment the number
of larvae in each pan varied, depending on the quantity available; in the
second experiment 300 larvae were always used in each pan. After 24 hours,
food consisting of powdered dog biscuit was added, and larvae were allowed to continue development in the
treated water until they reached the
pupal stage. Pupae were removed to
untreated water, and emerging adults
were allowed to remain together in a
screen cage for about S days to permit
mating. Females were then given a
blood meal on a guinea pig. A day
later a container which had been lined
with filter paper, and containing water
to keep the filter paper damp, was
placed in the cage for oviposition. Eggs
deposited by all the laying females
Table 1. Sterility of eggs from a colony of
Aedes aegypti exposed in the larval stage of
each generation to selection pressure with
apholate and from treated and untreated mosquitoes from the regular colony.
GenerSterilitY of mosation Concento apholate
apholate
colony

apholate
(ppm)

Apholate
colony
(%)

Sterility
from

Reg untreated
ular regular
Colony cOlony
(%)

(%)

Parent
1
2
3
4
5

5
5
5
5
5
15

Experiment I
96
89
75
59
46
72

2
20
48
3
6
2

Parent
1
2
3
4
5

5
5
5
5
5
5

Expe7^iment2
91
85
90
82
85
77

6
1
0
1
2
19

6
7
8
9
10
11

5
5
5
10
10
10
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38
52
50
81
88
59

84
93
100
100
100

15
8
17
4
18
4

were used to produce the next generation of the colony. In addition, the
percentage hatch of eggs laid in each
generation was determined separately.
In the first experiment females were
individually confined for oviposition,
and the percentage hatch was calculated for all eggs laid. In each generation 1000 to 5000 eggs were checked
for sterility. In the second experiment
a sample of about 200 eggs, taken at
random from eggs laid by all females
about 1 week after deposition, was
used to determine percentage hatch.
A complete cycle from third instar to
third instar required about 3 weeks.
In the second experiment, beginning
with the F7 generation of the apholatetreated colony, larvae from the regular colony were treated with the same
dosage of apholate as those in the
experimental colony. This procedure
provided a direct comparison between
the sterility induced in the selected and
in the unselected colonies. The percentage sterility in eggs from untreated
mosquitoes from the regular colony
was also determined in each generation
(Table 1) .
In the first experiment sterility of
eggs from females exposed to S ppm
of apholate gradually declined from 96
percent in the parent generation to
46 percent in the 4 generation. Larvae from the F6 generation were exposed to 15 ppm, a dosage which
usually causes complete or almost
complete sterility. Resulting sterility of
eggs from the females was 72 percent
or 24 percent less than that obtained
with the initial selection dosage of 5
ppm. The percentage sterility in the
control colony ranged from 2 percent
to 48 percent (average 13.5 percent);
however, in 4 out of the-6 hatchings
sterility was 6 percent or less.
In the second experiment, sterility
ranged from 77 percent to 91 percent
for the parent and first five generations, but decreased in the next three
generations (38 percent to 52 percent).
In the F9 generation the selection
concentration was increased to 10 ppm.
This concentration caused 81 percent
and 88 percent sterility in the next two
generations, but in the F generation
sterility dropped to 59 percent. At this
selection concentration, complete sterility was obtained with treated mosquitoes from the regular colony. In
addition, these females produced far
fewer eggs than females from the apholate colony. Sterility among untreated
control females ranged from O percent to 19 percent.

These data indicate that A. aegypti
can develop resistance to apholate.
The degree of resistance encountered
to date is not great, probably between
four and five times that of the normal
strain.
E. I. HAZARD,
C. S. LOFGREN
D. B. WOODARD
*, TI. R. FORDt
B. M. OLANCEY
Agr.iculturalResearch Service,
U.S. Department of Agriculture,
Gainesville, Florida
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Polydactylism in the Ofspring
of Mice Injected with
5-Bromodeoxyuridine
Abstract. The intraperitoneal injection of multiple doses of .S-bromodeoxyuridine (BUDR) into pregnant
mice produced abnormalities limited to
the h.ind limbs of the offspring. This
efgf
ect is probably a result of a metabolic lesion. When injected into newborn mice, BUDR did!noEtincrease the
incidence of tumors.
A mutagen, 5-bromodeoxyuridine
(BUDR), was investigated for possible
somatic effects on hybrid mice. The
potential carcinogenicity of this mutagen was also studied by direct treatment of newborn inbred mice. The
BUDR was selected because its mutagenic action is well understood ( 1 ),
and because it entexs the DNA of
mammalian cells while S-bromouracil
does not (2 ) .
Mice of strains A and C3H-MF were
used. The breeding mice were 3 to 5
months old and all the females were
virgin. The somatic effect of BUDR
was studied in hybrid embryos of
C3H-MF males and strain A females.
At the time of discovery of vaginal
plug, considered as zero time in gestation period, the pregnant females were
isolated in individual cages. The drug
was dissolved in isotonic saline, and a
501

